Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 9:9:25-36.
doi: 10.4137/CMPed.S21161. eCollection 2015.

Intravenous lipids for preterm infants: a review

Affiliations
Review

Intravenous lipids for preterm infants: a review

Ghassan Sa Salama et al. Clin Med Insights Pediatr. .

Abstract

Extremely low birth weight infants (ELBW) are born at a time when the fetus is undergoing rapid intrauterine brain and body growth. Continuation of this growth in the first several weeks postnatally during the time these infants are on ventilator support and receiving critical care is often a challenge. These infants are usually highly stressed and at risk for catabolism. Parenteral nutrition is needed in these infants because most cannot meet the majority of their nutritional needs using the enteral route. Despite adoption of a more aggressive approach with amino acid infusions, there still appears to be a reluctance to use early intravenous lipids. This is based on several dogmas that suggest that lipid infusions may be associated with the development or exacerbation of lung disease, displace bilirubin from albumin, exacerbate sepsis, and cause CNS injury and thrombocytopena. Several recent reviews have focused on intravenous nutrition for premature neonate, but very little exists that provides a comprehensive review of intravenous lipid for very low birth and other critically ill neonates. Here, we would like to provide a brief basic overview, of lipid biochemistry and metabolism of lipids, especially as they pertain to the preterm infant, discuss the origin of some of the current clinical practices, and provide a review of the literature, that can be used as a basis for revising clinical care, and provide some clarity in this controversial area, where clinical care is often based more on tradition and dogma than science.

Keywords: intravenous lipids (IL); preterm infant.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of triglycerides.
Figure 2
Figure 2
Structure of phospholipids.

Similar articles

Cited by

References

    1. Adamkin D, Gelke K, Andrews B. Fat emulsions and hypertriglyceridemia. JPEN J Parenter Enteral Nutr. 1984;8(5):563–7. - PubMed
    1. Van Aerde JE, Sauer PJ, Pencharz PB, Smith JM, Swyer PR. Effect of replacing glucose with lipid on the energy metabolism of newborn infants. Clin Sci. 1989;76(6):581–8. - PubMed
    1. Van Aerde JE, Sauer PJ, Pencharz PB, Smith JM, Heim T, Swyer P. Metabolic consequences of increasing energy intake by adding lipid to parenteral nutrition in full-term infants. Am J Clin Nutr. 1994;59(3):659–62. - PubMed
    1. Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of the very low birthweight infant. Clin Perinatol. 2002;29:225–44. - PubMed
    1. Innis SM, Adamkin DH, Hall RT, et al. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. J Pediatr. 2002;140(5):547–53. - PubMed

LinkOut - more resources